Bottom line
JAFMX vs JDOC: the short answer
JAFMX (Health Sciences Trust) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But JAFMX is far broader, holding 173 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 0.99% — a difference of $34 a year per $10,000 invested.
Over one year, JAFMX returned +19.5% vs +14.9% for JDOC.
Updated Nov 19, 2026
JAFMX vs JDOC side by side
| JAFMX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | John Hancock | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.99% | 0.65% |
| Annual cost per $10k | $99 | $65 |
| 10-yr cost on $10k (prospectus) | $1,224 | $810 |
| Max front load | — | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +19.5% | +14.9% |
| 5-yr return (annualized) | +4.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | — | +11.3% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $251.3M | $9.1M |
| Number of holdings | 173 | 61 |
| Portfolio turnover | 68% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of JAFMX's top 25 holdings also appear in JDOC's top 25.
| Holding | JAFMX | JDOC |
|---|---|---|
| Eli Lilly and Company | 14.30% | 7.76% |
| Johnson and Johnson | 6.33% | 4.82% |
| UnitedHealth Group Incorporated | 5.95% | 5.85% |
| AbbVie Inc. | 5.28% | 7.85% |
| Merck and Co. Inc. | 4.21% | 4.82% |
| Thermo Fisher Scientific Inc. | 2.67% | 3.73% |
| Bristol-Myers Squibb Company | 2.22% | 3.57% |
| Abbott Laboratories | 2.00% | 3.11% |
| Intuitive Surgical Inc. | 1.98% | 1.93% |
| Stryker Corporation | 1.87% | 2.23% |
| Danaher Corporation | 1.51% | 2.16% |
| Cardinal Health Inc. | 1.09% | 1.51% |
| CVS Health Corporation | 0.98% | 2.83% |
Source: SEC Form N-PORT
JAFMX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between JAFMX and JDOC?
Which is cheaper, JAFMX or JDOC?
Should I own both JAFMX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.